Estrogen increases smooth muscle expression of {alpha}2C-adrenoceptors and cold-induced constriction of cutaneous arteries

1 Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio; 2 Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and 3 Faculty of Veterinary Science, University of Melbourne, Parkville, Victoria, Australia Submitted 12 Ma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2007-09, Vol.293 (3), p.H1955
Hauptverfasser: Eid, A. H, Maiti, K, Mitra, S, Chotani, M. A, Flavahan, S, Bailey, S. R, Thompson-Torgerson, C. S, Flavahan, N. A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio; 2 Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and 3 Faculty of Veterinary Science, University of Melbourne, Parkville, Victoria, Australia Submitted 12 March 2007 ; accepted in final form 17 July 2007 Raynaud's phenomenon, which is characterized by intense cold-induced constriction of cutaneous arteries, is more common in women compared with men. Cold-induced constriction is mediated in part by enhanced activity of 2C -adrenoceptors ( 2C -ARs) located on vascular smooth muscle cells (VSMs). Experiments were therefore performed to determine whether 17 -estradiol regulates 2C -AR expression and function in cutaneous VSMs. 17 -Estradiol (0.01–10 nmol/l) increased expression of the 2C -AR protein and the activity of the 2C -AR gene promoter in human cultured dermal VSMs, which was assessed following transient transfection of the cells with a promoter-reporter construct. The effect of 17 -estradiol was associated with increased accumulation of cAMP and activation of the cAMP-responsive Rap2 GTP-binding protein. Transient transfection of VSMs with a dominant-negative mutant of Rap2 inhibited the 17 -estradiol-induced activation of the 2C -AR gene promoter, whereas a constitutively active mutant of Rap2 increased 2C -AR promoter activity. The effects of 17 -estradiol were inhibited by the estrogen receptor (ER) antagonist, ICI-182780 (1 µmol/l), and were mimicked by a cell-impermeable form of the hormone (estrogen:BSA) or by the selective ER- receptor agonist 4,4',4'''-(4-propyl-[ 1 H]-pyrazole-1,3,5-triyl)tris-phenol (PPT; 10 nmol/l) or the selective ER- receptor agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN; 10 nmol/l). Therefore, 17 -estradiol increased expression of 2C -ARs by interacting with cell surface receptors to cause a cAMP/Rap2-dependent increase in 2C -AR transcription. In mouse tail arteries, 17 -estradiol (10 nmol/l) increased 2C -AR expression and selectively increased the cold-induced amplification of 2 -AR constriction, which is mediated by 2C -ARs. An estrogen-dependent increase in expression of cold-sensitive 2C -ARs may contribute to the increased activity of cold-induced vasoconstriction under estrogen-replete conditions. Raynaud's phenomenon; Rap1; Rap2; adenosine 3',5'-cyclic monophosphate; estrogen receptors Address for reprint requests and other correspondence: N. A. Flavahan, Dept. of A
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.00306.2007